Seonix Bio's mission is to improve the treatment and prevention of blinding eye disease, through the development of advanced risk prediction tools.
Joined February 2022
- Tweets1
- Following0
- Followers7
- Likes0
Seonix Bio is pleased to announce it has been awarded a Seed-Start grant to accredit our glaucoma polygenic risk score for clinical use. Thank you to the SA government!
seonixbio.com/news
@DavidPisoniMP , @FIXEeffect
@Flinders , @QIMRBerghofer , @UTAS_